AMD3100联合G-CSF对糖尿病小鼠 骨髓内皮祖细胞的动员作用
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Role of AMD3100 combined with granulocyte colony-stimulating factor in the mobilization of bone marrow endothelial progenitor cells in diabetic mice
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:以糖尿病小鼠(db/db)为研究对象,比较单一使用AMD3100与AMD3100联合粒细胞集落刺激因子(granulocyte colony-stimulating,G-CSF)及两者不同使用顺序对骨髓内皮祖细胞(endothelial progenitor cells,EPCs)的动员效果,为临床获取糖尿病人EPCs进行细胞治疗提供思路。方法:采用AMD3100、重组人粒细胞集落刺激因子注射液(recombinant human granu-locyte colony-stimulating,rhG-CSF)参考国内外文献所述剂量和方法进行骨髓EPCs的动员。选用5~6周雄性小鼠,随机将80只db/db小鼠分为A组(AMD3100+NS动员组),B组(AMD3100+G-CSF动员组),C组(G-CSF+AMD3100动员组)和D组(NS空白对照组);80只db/+小鼠为相应对照组,分组对应为A’组,B’组,C’组和D’组。每组在动员后第3 、7、10、14 天4个时间点于心脏部位取外周血,流式细胞仪检测CD34+/CD133+/Flk-1+细胞的比例。结果取平均值用均值±标准差(单位%)表示,统计学方法处理后进行比较和分析。结果:①D组和D’组在动员后第3、7、10、14 天4个时间点,CD34+/CD133+/Flk-1+细胞比例无差异(P >0.05),但D’组中CD34+/CD133+/Flk-1+细胞比例高于D组(P=0.003)。②A组、B组和C组db/db小鼠在动员后第3、7、10、14 天4个时间点,CD34+/CD133+/Flk-1+细胞比例逐渐上升,A组至第7 天达到峰值,随后逐渐下降;B组和C组至第10 天达到峰值,随后逐渐下降,且在达到峰值时CD34+/CD133+/Flk-1+细胞比例与其余3个时间点相比差异有意义(P=0.000)。在第10 天,B组和C组db/db小鼠外周血中CD34+/CD133+/Flk-1+细胞比例较A组和D组高(P=0.000),但B组和C组db/db小鼠外周血中CD34+/CD133+/Flk-1+细胞比例之间的差异无统计学意义(P >0.05)。③A’组、B’组和C’组db/+小鼠在动员后第3、7、10、14天4个时间点,CD34+/CD133+/Flk-1+细胞比例逐渐上升,至第7 天达到高峰,随后逐渐下降,且在第7天CD34+/CD133+/Flk-1+细胞比例与其余3个时间点相比差异有意义(P=0.000)。在达到峰值的第7天,C’组CD34+/CD133+/Flk-1+细胞比例较A’组、B’组和D’组高(P=0.000)。结论:AMD3100联合G-CSF动员骨髓EPCs的效果优于单一使用AMD3100的动员效果,在非糖尿病状态下,先使用G-CSF再联合AMD3100的动员作用更优,但在糖尿病状态下先使用AMD3100再联合G-CSF的动员作用更优。

    Abstract:

    Objective:To investigate the role of AMD3100 and granulocyte colony-stimulating(G-CSF) used alone or in different se-quences in the mobilization of bone marrow endothelial progenitor cells(EPCs) in diabetic mice(db/db mice),and to provide thoughts for collecting EPCs from diabetic patients for clinical treatment. Methods:With reference to the dose and methods described in related articles in China and foreign countries,AMD3100 and recombinant human granulocyte colony-stimulating(rhG-CSF) injection were used for the mobilization of bone barrow EPCs. A total of 80 male db/db mice aged 5-6 weeks were randomly divided into group A (AMD3100+NS mobilization group),group B(AMD3100+G-CSF mobilization group),group C(G-CSF+AMD3100 mobilization group),and group D (NS blank control group). A total of 80 db/+ male mice were selected as corresponding controls and were divided into groups A’,B’,C’,and D’. Peripheral blood samples were collected from the heart on days 3,7,10,and 14 after mo-bilization,and flow cytometry was used to measure the proportion of CD34+/CD133+/Flk-1+ cells. The results were expressed as mean±standard deviation(%),and comparison and analysis were per-formed after statistical analysis. Results:On days 3,7,10,and 14 after mobilization,there was no significant difference in the proportion of CD34+/CD133+/Flk-1+ cells between groups D and D’(P>0.05),but group D’ had a higher proportion than group D(P=0.003). In group A,the proportion of CD34+/CD133+/Flk-1+ cells gradually increased and reached the highest value on day 7 and then gradually decreased;in groups B and C,the proportion of CD34+/CD133+/Flk-1+ cells gradually increased and reached the highest value on day 10 and then gradually decreased;the proportion of CD34+/CD133+/Flk-1+ cells at the peak was significantly higher than that at the other three time points(P=0.000). On day 10,groups B and C had a significantly higher proportion of CD34+/CD133+/Flk-1+ cells in peripheral blood of db/db mice than groups A and D(P=0.000),but there was no significant difference between groups B and C(P>0.05). In groups A’,B’, and C’ after mobilization,the proportion of CD34+/CD133+/Flk-1+ cells gradually increased and reached the peak on day 7 and then gradually decreased;the proportion of CD34+/CD133+/Flk-1+ cells on day 7 was significantly higher than that at the other three time points(P=0.000). On day 7,the C’ group had a significantly higher proportion of CD34+/CD133+/Flk-1+ cells than groups A’,B’, and D’(P=0.000). Conclusion:AMD3100 combined with G-CSF has a better effect in the mobilization of bone marrow EPCs than AMD3100 alone. In non-diabetic conditions,G-CSF followed by the addition of AMD3100 has a better mobilization effect,but in diabetic conditions,AMD3100 followed by the addition of G-CSF has a better mobilization effect.

    参考文献
    相似文献
    引证文献
引用本文

林晓莹,汪虹. AMD3100联合G-CSF对糖尿病小鼠 骨髓内皮祖细胞的动员作用[J].重庆医科大学学报,2019,(3):247-

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-04-30
  • 出版日期:
文章二维码